Overview of 1st Wave Pipeline

Product Therapeutic Area
GC-1 Arthritis
GC-2 Hypertension
GC-3 Anti-arrthythmic
GC-4 Hypertension / Angina
GC-5 Hypertension
GC-6 Epilepsy

Overview of 2nd Wave Pipeline

Product Therapeutic Area
GC-7 Hypnotic
GC-8 Anti-cholinergic
GC-9 Hypertension
GC-10 Pain - CII
GC-11 Pain - CII

Overview of 3rd Wave Pipeline

Product Therapeutic Area
GC-12 Asthma
GC-13 Urinary Incontinence
GC-14 ADHD
GC-15 ADHD

Overview of 4th Wave Pipeline

Product Therapeutic Area
GC-16 Cardiovascular
GC-17 Endocrinology
GC-18 Hypokalemia
GC-19 Pain

Overview of 5th Wave Pipeline

Product Therapeutic Area
GC-20 CV
GC-21 Renal
GC-22 Asthma

Overview of 6th Wave Pipeline

Product Therapeutic Area
GC-23 Oncology
GC-24 Vitamins
GC-25 CNS
GC-26 Oncology
GC-27 Cardiovascular
GC-28 CNS

Overview of 7th Wave Pipeline

Product Therapeutic Area
GC-29 Gastrointestinal
GC-30 Antifungal
GC-31 ADHD
GC-32 Hypertension
GC-33 Schizophrenia
GC-34 Diabetes

In-Licensed

Product Therapeutic Area
GCL-1 Gastrointestinal

Paragraph IVs

Product Therapeutic Area
GCIV 1-14 (confidential)